Chemosensory Patients in Cancer Patients (Week 3 Lecture 1) Flashcards

1
Q

A healthy sense of taste and smell….

A
  • Positively influences appetite, food choice, dietary intake and nutritional status.
  • Results in food enjoyment and enhanced food-related quality of life.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sensory Nutrition

A

links chemosensation and food choice.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NIS

A

Nutrition Impact Symptoms: reduce appetite, nutritional status and quality of life for patients with cancer.
* Anorexia
* Pain
* Nause
* Vomiting
* Diarrhea
* Early Satiety
* Taste & smell distortion
* Mucositis
* Fatigue
* Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does TSA change over the course of chemotherapy treatment?

A

At each next cycle the symptoms increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

prevalency of TSAs in cancer patients

A

On average, studies report a prevalence of 60 to 75% overall patient groups (Drareni et al. 2019)
According to the review of Hovan et al. (2010):
* 50% of patients treated only with CT
* 66% of patients treated only with RT
* 75% of patients treated with CT & RT
* 15% of RT-treated patients experience TSAs post- treatment.

86% of patients with advanced cancer (Hutton et al. 2007)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How might TSA progress?

A
  1. Symptoms from cancer (disease, treatment) interfere with eating
  2. taste & smell perception is changed
  3. food choice is restricted
  4. specialized nutritional needs develop
  5. Eating experience changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

flavour

A

the combined perception of aroma, taste and oral taste sensations
* smell is accounts for about 80% of what we taste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chemosensation

A

The combined perception of gustation and olfaction (taste and smell)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Challenges of communicating TSAs

A
  • ‘Technical’ versus ‘everyday’ terminologies; clinician versus patient perspectives
  • Patients may identify a change in liking of foods prior to, or instead of, a TSA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What question is more useful to patients to identify TSA?

A

Have you ever noticed that a food tastes different than it used to?
* … a food smells …?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do clinicians and researchers assess taste and smell function?

A

A variety of clinical tests are available to determine thresholds (intensity of
stimulus) and to assess identification ability (quality).
* Use of taste threshold assessments was prevalent in the 1970’s and 1980’s; use of smell assessments is more recent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Current clinical testing tools

A
  • taste strips
  • BSIT - Sniffin’ Sticks and Brief Smell Identification Tests (BSIT)
  • scratch and sniff test (if normal sense of smell would get it correct)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Current approaches to taste and smell testing

A
  • ‘Whole mouth’ taste assessments to parallel the eating experience (glucose in koo-laide, NaCl in tomato juice)
  • Basic taste assessments in food matrices
  • Usually assessment of both taste and smell
  • Self-assessment tools (Patient Reported Outcomes; PRO)
  • Interviews in qualitative studies provide rich descriptions of patient experiences.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Self-Assessment Measures of TSA

A
  • Individual items on Quality of Life, symptom assessment and nutrition assessment tools → E.g. PG-SGA (“tastes bother me”)
  • Symptom specific tools → Short questionnaires, Comprehensive surveys
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The strengths of a self- assessment tool?

A
  • Patient perception of TSA dictates food choice
  • The quantitative dimension allows population stratification and statistical associations to other data (i.e. energy intake, quality of life, severity to weight loss)
  • The qualitative dimension generates a description of the impact of the TSA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do we know about the nature of TSAs?

A

It varies, each individual is unique
* TSA can exist as stronger or weaker perceptions of the basic tastes and sense of smell.
* An individual may experience both stronger and weaker perceptions (“mixed”)
* The pattern of response is unique to the individual but three phenotypes were observed (stronger, weaker, mixed)

17
Q

Study looking at the impact of TSA amoung patients with advanced cancer

A

66 advanced cancer patients completed:
* The Taste and Smell Survey
* A 3 day dietary record for analysis of energy, macronutrients and food groups
* A quality of life tool (FAACT: Functional Assessment of Anorexia/ Cachexia Therapy)

Found that the more severe TSA was there was
* ↓ energy intake (including protein)
* ↑ weight loss
* ↑ time to death
* ↓ QoL

18
Q

What dietary patterns have been found to maybe be associated with severe TSA?

A

As TSA increased in severity and number of complaints…
* daily energy and protein intake decreased
* dietary pattern shifted to bland and liquid ‘foods’

associated not causal

19
Q

TSA in head and neck patients

A

TSA is can extend well beyond post treatment
* Patients (n=160) received treatment for HNC (RT or CRT,+/- surgery) and were capable of oral intake and completed all three study time points. TSA were highest at the end of treatment (post treatment) and persisted after treatment for many patients
* ‘Taste’ was the 4th most important QOL issue at end treatment and 2.5 months post-treatment
* The eating experience is exacerbated by a plethora of oral complications

20
Q

Changing nature of TSA over time

A

It varies greatly on the individual but tastes can changes drastical from normal to weaker/stronger/mixed
* Trajectory of self-reported sweet taste intensities relative to time of diagnosis for patients (n=42) providing data at all three study time points

21
Q

Effects of taste changes on patients’ usual activities

A
22
Q

What have studies looked at with TSA?

A
  • There are many studies of TSA → Prevalence, Impact, Assessment
  • There are few studies of TSA → Causes, Management
23
Q

What contributes to TSA?

A

Alterations in taste perception in cancer are multi-factorial.

24
Q

Management and support for taste and smell alterations

A
  1. Remedies, medications or treatments
  2. Product development tailored to the food preferences and NIS of cancer patients.
  3. Generalised management strategies for TSA suggested at clinics and on-line.
  4. Selective taste management
25
Q

Remedies, medications or treatments

A

Zinc supplementation interventions to treat TSA
* Results are conflicting; the result of different doses and endpoint measurements?

Preventive interventions
* Megestrol acetate, Oral glutamine, Amifostine, Bethanecol
* Self-care strategies (taste change suggestion sheet)
* Miracle fruit
* Marinol (Delta-9-tetrahydrocannabinol (THC))

No effective treatment - not enough evidence for these

26
Q

Product development tailored to the food preferences and NIS of cancer patients.

A
  • Development of convenient taste & texture appealing comfort foods by Hormel foods.
  • Supplemented and fortified foods described in the literature such as ice cream, jelly, beverages, ‘traditional’ entrées
27
Q

Parameters to consider when developing a new product for cancer patients

A

Provide pleasure of eating, prevent malnutrition and provide a better QOL

28
Q

Generalised management strategies for TSA

A
  • Pick and choose those “tips” that work for patient as the nature of the alteration is unique to the individual (taste change management information is available from many health authorities and treatment centres)
  • Reassure patient that the TSA experience is ‘not unusual’.
  • ‘Supportive food networking’; patients share their experience with TSA management and food choices (asking what foods are still available)
  • suggest snacks which may limit sensory exposure, accomodate changes in preference and may increase caloric intake
29
Q

Selective taste management

A

Food choice or individual foods are refined by the individual to reflect their unique taste preferences.

Study → Intervention group received IMTD (Interventions to Mitigate Taste Dysfunction)
* Manage dry mouth and enhance food liquefaction,
* Focus on mindful eating; ‘eating as a sensory experience’,
* Individualized seasoning adjustment and food choices based on taste assessment results.

Study → After patient taste assessments, personalized bread formulations were provided by chefs.
* Of the participants, 11 participated in interviews to describe the experience; 5 themes were identified

30
Q

Conclusion of TSA

A
  • TSA are nutrition impact symptoms among patients with cancer that → interfere with appropriate and adequate dietary intake, reduce quality of life and social enjoyment.
  • Self-assessment tools for TSA provide insight into patient perception, which determines food choice.
  • TSA are unique to the patient and change over time.
  • There are no remedies for TSA however customized supports show benefits.